Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by krbcanon Jun 12, 2018 7:53am
81 Views
Post# 28158350

RE:For new Investors or those considering !

RE:For new Investors or those considering !
Thor6570 wrote:
I have copied for your convience news releases that will make it easy for you to quickly read up and learn exactly what this company is achieving. All fo >$.40 cents. Ground floor baby could be the once in a lifetime investment anyhow good luck and welcome if you choose to invest. PS this board is loaded with great posts from investors whom know and or really dug deep to lear about the science and company. It is not all rosy here as the board has been under siege for some time by organized stock bashers
led by the scalliwag Bionicjoe. Simply ignore him as he simply lies and distorts fact ( sound familiar ) 

Latest news on THERALASE TECHNOLOGIES INC
06/11 THERALASE TECHNOLOGIES : ® Demonstrates Significant Advantage in Treatment of Br..
AQ
06/08 THERALASE TECHNOLOGIES : Demonstrates 36 Months Stability of Lead Anti-Cancer Dr..
AQ
06/06 THERALASE TECHNOLOGIES : Demonstrates 36 Months Stability of Lead Anti-Cancer Dr..
AQ
06/01 THERALASE TECHNOLOGIES : Release 1Q2018 Financial Statements
AQ
05/30 THERALASE TECHNOLOGIES : Release 1Q2018 Financial Statements
AQ
05/30 THERALASE TECHNOLOGIES : Successfully Completes Phase Ib Non-Muscle Invasive Bla..
AQ
05/18 THERALASE TECHNOLOGIES : Announces Completion of Non-Brokered Private Placement ..
AQ
05/17 THERALASE TECHNOLOGIES : Provides Update on Phase Ib Non-Muscle Invasive Bladder..
AQ
05/14 THERALASE TECHNOLOGIES : Announces Completion of Non-Brokered Private Placement ..
AQ
05/14 THERALASE TECHNOLOGIES : Announces Proposed Non-Brokered Private Placement of up..
AQ
05/08 THERALASE TECHNOLOGIES : Announces Proposed Non-Brokered Private Placement of up..
AQ
04/30 THERALASE TECHNOLOGIES : Increases Revenue 22% for 2017 Financial Statements
AQ
04/18 THERALASE TECHNOLOGIES : Provides Update on Phase Ib Non-Muscle Invasive Bladder..
AQ
04/16 THERALASE TECHNOLOGIES : Provides Update on Phase Ib Non-Muscle Invasive Bladder..
AQ
03/27 THERALASE TECHNOLOGIES : Discovers Cannabinoid Increases Efficacy of Patented An..
AQ
03/19 THERALASE TECHNOLOGIES : Anti-Cancer Technology Effective in Destroying Brain Ca..
AQ
03/15 THERALASE TECHNOLOGIES : Anti-Cancer Technology Effective in Destroying Brain Ca..
AQ
03/12 THERALASE TECHNOLOGIES : Rutherrin Technology Granted Allowance for Canadian Pat..
AQ
03/08 THERALASE TECHNOLOGIES : Advances Anti-Cancer Technology in Destruction of Human..
AQ
03/07 THERALASE TECHNOLOGIES : Rutherrin® Technology Granted Allowance for Canadian Pa..
AQ
03/05 THERALASE TECHNOLOGIES : Uses Light to Destroy Lung Cancer Cells in Lab Studies
AQ
03/05 THERALASE TECHNOLOGIES : Advances Anti-Cancer Technology in Destruction of Human..
AQ
02/28 THERALASE TECHNOLOGIES : Announces Settlement Agreement with Ontario Securities ..
AQ
02/26 THERALASE TECHNOLOGIES : Announces Settlement Agreement with Ontario Securities ..
AQ
02/13 THERALASE TECHNOLOGIES : Anti-Cancer Technology Treats Sixth Patient for Bladder..
AQ
02/09 THERALASE TECHNOLOGIES : Anti-Cancer Technology Treats Sixth Patient for Bladder..
AQ
01/18 CORRECTING AND REPLACING : Theralase Anti-Cancer Technology Used to Treat Fifth ..
AQ
01/18 THERALASE TECHNOLOGIES : Anti-Cancer Technology Used to Treat Fifth Patient for ..
AQ
01/17 THERALASE TECHNOLOGIES : Optimizes Delivery Schedule of Anti-Cancer Vaccine in D..
AQ
2017 THERALASE TECHNOLOGIES : Discovers Cold Laser Therapy Enhances Cancer Destructio..
AQ
2017 THERALASE TECHNOLOGIES : Discovers ® Cold Laser Therapy Enhances Cancer Destruct..
AQ
2017 THERALASE TECHNOLOGIES : Increases Revenue 12% for 3Q2017 Financial Statements
AQ
2017 THERALASE TECHNOLOGIES : Therapeutic Laser Technology Enhances Cancer Destructio..
AQ
2017 THERALASE TECHNOLOGIES : Therapeutic Laser Technology Enhances Cancer Destructio..
AQ
2017 THERALASE TECHNOLOGIES : Anti-Cancer Vaccine Validated in Colorectal Cancer
AQ
2017 THERALASE TECHNOLOGIES : Demonstrates 24 Months Stability of Second Clinical Bat..
AQ
2017 THERALASE TECHNOLOGIES : Anti-Cancer Vaccine Validated in Colorectal Cancer
AQ
2017 THERALASE TECHNOLOGIES : Demonstrates 24 Months Stability of Second Clinical Bat..
AQ
2017 THERALASE TECHNOLOGIES : Demonstrates 24 Months Stability of Second Clinical Bat..
AQ
2017 THERALASE TECHNOLOGIES : Discovers New Anti-Cancer Vaccine
AQ
2017 THERALASE TECHNOLOGIES : Discovers New Anti-Cancer Vaccine
AQ
2017 THERALASE TECHNOLOGIES : IIROC Trading Resumption - TLT
AQ
2017 THERALASE TECHNOLOGIES : IIROC Trading Halt - TLT
AQ
2017 IIROC Trade Halt - Theralase Technologies Inc.
NE
2017 THERALASE TECHNOLOGIES : IIROC Trade Halt - Theralase Technologies Inc.
AQ
2017 THERALASE TECHNOLOGIES : Researcher Discovers Super Potent Anti-Cancer Drugs
AQ
2017 THERALASE TECHNOLOGIES : Provides Interim Data Analysis on Anti-Cancer Treatment..
AQ
2017 THERALASE TECHNOLOGIES : Anti-Cancer Drugs Independently Reviewed
AQ
2017 THERALASE TECHNOLOGIES : Research to be Presented at International Conference
AQ
2017 THERALASE TECHNOLOGIES : Lead Anti-Cancer Drug Effective in the Destruction of B..
AQ
2017 THERALASE TECHNOLOGIES : Demonstrates 24 Month Stability of Lead Anti Cancer Dru..
AQ
2017 THERALASE TECHNOLOGIES : Lead Anti-Cancer Drug Effective in the Destruction of T..
AQ
2017 THERALASE TECHNOLOGIES : Demonstrates 24 Month Stability of Lead Anti-Cancer Dru..
AQ
2017 THERALASE TECHNOLOGIES : Demonstrates Increased Efficacy for Latest Anti-Cancer ..
AQ
2017 THERALASE TECHNOLOGIES : Anti-Cancer Drugs Effective in the Destruction of Cervi..
AQ
2017 THERALASE TECHNOLOGIES : Increases Revenue 14% for 2Q2017 Financial Statements
AQ
2017 THERALASE TECHNOLOGIES : Anti Cancer Drugs Independently Verified and Validated
AQ
2017 THERALASE TECHNOLOGIES : Anti-Cancer Drugs Independently Verified and Validated
AQ
2017 THERALASE TECHNOLOGIES : AntiCancer Technology Effective for the Destruction of ..
AQ
2017 THERALASE TECHNOLOGIES : Anti-Cancer Technology Effective for the Destruction of..
AQ
2017 THERALASE TECHNOLOGIES : PDT Technology Used to Treat Fourth Patient for Bladder..
AQ
2017 THERALASE TECHNOLOGIES : PDT Technology Used to Treat Fourth Patient for Bladder..
AQ
2017 THERALASE TECHNOLOGIES : Achieves Exploratory Endpoint of Efficacy for Anti Canc..
AQ
2017 THERALASE TECHNOLOGIES : shares rocket on TLD-1433 clinical trial findings
AQ
2017 THERALASE TECHNOLOGIES : Achieves Exploratory Endpoint of Efficacy for Anti-Canc..
AQ
2017 THERALASE TECHNOLOGIES : Releases Annual and Special Meeting Videos
AQ
2017 THERALASE TECHNOLOGIES : Provides Clarification Regarding Certain Forward Lookin..
AQ
2017 THERALASE TECHNOLOGIES : Provides Clarification Regarding Certain Forward-Lookin..
AQ
2017 THERALASE TECHNOLOGIES : Technology Proven Effective for the Treatment of Arthri..
AQ
2017 THERALASE TECHNOLOGIES : Researcher Granted Second US Patent for Novel Anti Canc..
AQ
2017 THERALASE TECHNOLOGIES : Researcher Granted Second US Patent for Novel Anti-Canc..
AQ
2017 OTCQX and OTCQB Companies To Present at 2017 Marcum MicroCap Conference
AQ
2017 THERALASE TECHNOLOGIES : Presents Phosphorescent Photosensitizers at Internation..
AQ
2017 THERALASE TECHNOLOGIES : Presents X-Ray Activation at International World Congre..
AQ
2017 THERALASE TECHNOLOGIES : Presents Dosimetry Planning at International World Cong..
AQ
1  2Next
  
 
Chart THERALASE TECHNOLOGIES INC
Duration : Period :
   



Here again is Thor's post from earlier today that BJ the paid basher is trying to bump down.

https://www.stockhouse.com/companies/bullboard?symbol=v.tlt&postid=28158206
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities